Sands Capital Management Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Sands Capital Management reduced its stake in Monsanto Company by 11.44% during the most recent quarter end. The investment management company now holds a total of 9,769,011 shares of Monsanto Company which is valued at $1,028,188,408 after selling 1,261,642 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Monsanto Company makes up approximately 2.89% of Sands Capital Management’s portfolio.

Other Hedge Funds, Including , Oppenheimerfunds reduced its stake in MON by selling 57,556 shares or 18.36% in the most recent quarter. The Hedge Fund company now holds 255,920 shares of MON which is valued at $26,935,580. Monsanto Company makes up approx 0.03% of Oppenheimerfunds’s portfolio.Dimensional Fund Advisors Lp reduced its stake in MON by selling 13,220 shares or 1.32% in the most recent quarter. The Hedge Fund company now holds 985,227 shares of MON which is valued at $105,172,982. Monsanto Company makes up approx 0.06% of Dimensional Fund Advisors Lp’s portfolio.Commerce Bank reduced its stake in MON by selling 16,507 shares or 12.38% in the most recent quarter. The Hedge Fund company now holds 116,777 shares of MON which is valued at $12,369,020. Monsanto Company makes up approx 0.19% of Commerce Bank’s portfolio.Royal London Asset Management Ltd reduced its stake in MON by selling 47,242 shares or 24.24% in the most recent quarter. The Hedge Fund company now holds 147,685 shares of MON which is valued at $15,412,407. Monsanto Company makes up approx 0.24% of Royal London Asset Management Ltd’s portfolio.

Monsanto Company opened for trading at $107.86 and hit $108.26 on the upside on Monday, eventually ending the session at $107.54, with a gain of 0.13% or 0.14 points. The heightened volatility saw the trading volume jump to 24,26,569 shares. Company has a market cap of $47,057 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Investors should note that on Aug 12, 2016, Monsanto Company announced a cash dividend of $0.5400. The company’s management has announced Oct 5, 2016 as the ex-dividend date and fixed the record date on Oct 7, 2016. The payable date has been fixed on Oct 28, 2016.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.